Insider Transactions in Q1 2025 at National Health Investors Inc (NHI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2025
|
Robert G Adams Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
32,935
-8.78%
|
$2,437,190
$74.7 P/Share
|
|
Mar 28
2025
|
Robert G Adams Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
45,000
+3.95%
|
$2,475,000
$55.3 P/Share
|
|
Mar 03
2025
|
D. Eric Mendelsohn CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+7.65%
|
-
|
|
Mar 03
2025
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+6.07%
|
-
|
|
Mar 03
2025
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+8.23%
|
-
|
|
Mar 03
2025
|
John L Spaid CFO/EVP Finance |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+12.7%
|
-
|
|
Mar 03
2025
|
David L Travis SVP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+20.33%
|
-
|
|
Feb 23
2025
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-0.69%
|
$18,156
$68.96 P/Share
|
|
Feb 23
2025
|
D. Eric Mendelsohn CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-0.3%
|
$18,156
$68.96 P/Share
|